August 18, 2022 News by Margarida Maia, PhD Eye Scans May Help to Diagnose MS in Children A machine learning approach based on eye scans was employed by researchers to diagnose multiple sclerosis (MS) in children with up to 80% accuracy. Optical coherence tomography (OCT) scans also provided enough data to diagnose other demyelinating diseases with 75% accuracy. OCT is an imaging tool that uses…
July 20, 2021 News by Forest Ray PhD Nerve Tissue Scarring May Explain MS Progression Nerve tissue scars associated with multiple sclerosis (MS) show marked differences from those of similar neurodegenerative disorders, according to a recent study. MS-associated inflammation causes brain and spinal cord lesions (nerve tissue scarring) that often are bigger and last longer than those of two other demyelinating diseases: myelin oligodendrocyte…
December 13, 2019 News by Marisa Wexler, MS MetP Pharma Awarded US Patent for Potential Remyelination Therapy MetP Pharma‘s patent application for a new method to treat demyelinating and neuroinflammatory diseases, including multiple sclerosis (MS), has been approved by the United States Patent and Trademark Office (USPTO). The patent, titled āTreatment of Demyelinating Diseasesā (U.S. Appl. No. 16/506,830), is valid until 2039,…
July 23, 2018 News by Iqra Mumal, MSc Hypertension More Common in MS Patients Than General Public, Study Reports People with multiple sclerosis are 48 percent more likely to have high blood pressure compared to the general population ā and to people with other demyelinating diseases, a new study reports. Its researchers also emphasize that hypertension is already linked to poorer outcomes in MS patients. The study, āCardiovascular…
November 6, 2017 News by Iqra Mumal, MSc Thin But Persistent Regrowth of Myelin Layers Sign of Health in CNS, Study Says The generation of a thin myelin sheath during remyelination ā one that continues to protect nerve cells over time ā is indicative of the long-term health and activity of the central nervous system (CNS) in demyelinating diseases such as multiple sclerosis (MS), a new study shows. These findings, which aim…
October 24, 2016 News by Patricia Inacio, PhD Study of Myelin-producing Cells a Step Forward for MS, Other Neurological Disorders A study found that the cells responsible for the production of myelinĀ selectively introduce a myelin-insulating layer in a particular set of neuronal axons in the brainās white matter. This represents a step forward in the basic mechanisms that may underlie neurological disorders, including multiple sclerosis (MS). Also, aĀ newly developed method…
August 22, 2016 News by InĆŖs Martins, PhD Umbilical Cord Blood-derived Cell Therapy Promotes Remyelination in Mice A cell therapy product derived from human umbilical cord blood cells may be a promising treatment approach for patients with demyelinating diseases, such as multiple sclerosis (MS) or leukodystrophy, according to a recent study developed at theĀ Duke University Medical Center. The study, “A cord blood monocyteāderived cell…
April 6, 2016 News by Patricia Silva, PhD MS-associated Myelitis Can Be Identified Early Through MRI Scans, Study Reports Researchers reported that patients with myelitis who later develop multiple sclerosis (MS) might be distinguished from others with myelitis by a number of characteristics, like the location and size of spinal cord lesions, a finding that might help clinicians diagnose MS and initiate treatment at an early stage. Myelitis, an…